Apple peel polyphenols: a key player in the prevention and treatment of experimental inflammatory bowel disease.

Abstract

Diets rich in fruits and vegetables may reduce oxidative stress (OxS) and inflammation via several mechanisms. These beneficial effects may be due to their high polyphenol content. The aims of the present study are to evaluate the preventive and therapeutic aspects of polyphenols in dried apple peel powder (DAPP) on intestinal inflammation while elucidating the underlying mechanisms and clinical benefits. Induction of intestinal inflammation in mice was performed by oral administration of the inflammatory agent dextran sulfate sodium (DSS) at 2.5% for 10 days. Physiological and supraphysiological doses of DAPP (200 and 400 mg/kg/day respectively) were administered by gavage for 10 days pre- and post-DSS treatment. DSS-mediated inflammation caused weight loss, shortening of the colon, dystrophic detachment of the epithelium, and infiltration of mono- and poly-morphonuclear cells in the colon. DSS induced an increase in lipid peroxidation, a down-regulation of antioxidant enzymes, an augmented expression of myeloperoxidase (MPO) and cyclooxygenase-2 (COX-2), an elevated production of prostaglandin E2 (PGE2) and a shift in mucosa-associated microbial composition. However, DAPP normalized most of these abnormalities in preventive or therapeutic situations in addition to lowering inflammatory cytokines while stimulating antioxidant transcription factors and modulating other potential healing pathways. The supraphysiological dose of DAPP in therapeutic situations also improved mitochondrial dysfunction. Relative abundance of Peptostreptococcaceae and Enterobacteriaceae bacteria was slightly decreased in DAPP-treated mice. In conclusion, DAPP exhibits powerful antioxidant and anti-inflammatory action in the intestine and is associated with the regulation of cellular signalling pathways and changes in microbiota composition. Evaluation of preventive and therapeutic effects of DAPP may be clinically feasible in individuals with intestinal inflammatory bowel diseases.

• Authors: Marie-Claude Denis, Denis Roy, Pantea Rahmani Yeganeh, Yves Desjardins, Thibault Varin, Nour Haddad, Devendra Amre, Alain Théophile Sané, Carole Garofalo, Alexandra Furtos, Natalie Patey, Edgard Delvin, Eric Tremblay, André Marette, Jean-François Beaulieu, Emile Levy
• Journal: Clinical science (London, England : 1979) (Clin Sci (Lond)) Vol. 130 Issue 23 Pg. 2217-2237 (12 01 2016) ISSN: 1470-8736 [Electronic] England
• PMID: 27630205 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: © 2016 The Author(s). published by Portland Press Limited on behalf of the Biochemical Society.

Chemical References

• Anti-Inflammatory Agents
• Antioxidants
• Plant Extracts
• Polyphenols
• Cyclooxygenase 2

Topics

• Animals
• Anti-Inflammatory Agents (administration & dosage)
• Antioxidants (administration & dosage)
• Cyclooxygenase 2 (metabolism)
• Fruit (chemistry)
• Humans
• Inflammatory Bowel Diseases (drug therapy, metabolism, microbiology)
• Male
• Malus (chemistry)
• Mice
• Mice, Inbred C57BL
• Oxidative Stress
• Plant Extracts (administration & dosage)
• Polyphenols (administration & dosage)